Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck.

Ther Clin Risk Manag · 2007 · PMC2376084 · PMID 18473010

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The progression free survival (PFS) and the overall survival (OS) showed a trend in favor of arm A, but did not meet the statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.